Pharmaceutical Information - September 7, 2008

FDA Notes Two More Deaths Linked To Amylin's Diabetes Drug Byetta

August 18, 2008 - Topics diabetes, byetta, fda, hospital and pharmaceutical
Eli Lilly & Co. and Amylin Pharmaceuticals Inc.'s diabetes drug Byetta on Monday received a federal warning after the drug was linked to deaths in two patients with an inflamed pancreas and four other hospitalizations.

The U.S. Food and Drug Administration (FDA) now plans to strengthen warnings about life-threatening pancreas problems linked to the type 2 diabetes drug. Those who died were among six Byetta users who entered the hospital since October because of a condition known as acute pancreatitis (inflammation of the pancreas with bleeding). Their Byetta treatment was stopped and the four survivors were still recovering, the FDA posted on its website

read more >>

Commonly Used Moisturizing Creams Found To Promote Tumors In Mice

August 14, 2008 - Topics cancer, skin cancer, radiation, pharmaceutical and safety
Certain commonly used skin creams like moisturizers induced skin cancer in experiments on mice, a study released Thursday said, and experts are checking to see if they might cause growths in people as well.

Allan Conney and colleagues at Rutgers University in New Jersey said they tested four common skin creams on gene-altered hairless mice exposed to heavy doses of cancer-causing UV light

read more >>

Drug Prices Forecast To Double In Next 4 Years

August 8, 2008 - Topics pharmaceutical, medicine, research, sleep and study
Like fuel, prices of drugs have been soaring from 100 percent even up to 1,000 percent, according to researchers at the University of Minnesota.

What is alarming is the prices of medicine could escalate further and double again in the next four years, the researchers said. The study said the average wholesale price of 26 brand-name drugs doubled in a single cost adjustment in 2007

read more >>

FDA Advisory Panel Recommends Approval Of Roche's Arthritis Drug Actemra

July 29, 2008 - Topics arthritis, fda, disease, immune and disorder
Outside medical experts for the Food and Drug Administration (FDA) on Tuesday recommended approval of Roche Holding AG's drug Actemra to treat moderate to severe rheumatoid arthritis.

The drug is more effective at reducing symptoms of rheumatoid arthritis than existing biologic agents, which are dominated by a type of drug known as anti-TNFs. The new drug will target the drug for patients who failed anti-TNFs, such as Johnson & Johnson's drug Remicade and Abbott Laboratories' Humira, DowJones reported

read more >>

Hospital Says Pharmacy Error Led To Heparin Overdose Deaths Of Babies

July 11, 2008 - Topics hospital, babies, baby, infant and studies
A Texas hospital here has acknowledged an error occurred in its pharmacy that caused the death of two newborn twins.

Although the hospital says doctors found no direct links to the overdose, as many as 17 babies were given overdoses of the blood thinner Heparin at the neonatal intensive care unit of Christus Spohn Hospital South on July 4

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use